
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $492.6M | $614.8M | $193M | $207.6M | $217.5M | |
Revenue Growth (YoY) | -39.93% | 24.8% | -68.61% | 7.59% | 4.74% | |
Cost of Revenues | $473.3M | $529.6M | $133M | $135.1M | $140.4M | |
Gross Profit | $19.4M | $85.2M | $60M | $72.6M | $77.1M | |
Gross Profit Margin | 3.93% | 13.86% | 31.09% | 34.94% | 35.46% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $86.6M | $94.4M | $48.8M | $51.1M | $46M | |
Other Inc / (Exp) | -$17.7M | -$603K | -$9.2M | $889K | -$869K | |
Operating Expenses | $83.3M | $94.1M | $45.6M | $49.6M | $44.8M | |
Operating Income | -$63.9M | -$8.8M | $14.4M | $22.9M | $32.4M | |
Net Interest Expenses | $11M | $8.8M | $3.5M | $4.1M | $2.6M | |
EBT. Incl. Unusual Items | -$92.6M | -$18.2M | $1.7M | $19.7M | $28.9M | |
Earnings of Discontinued Ops. | -- | -- | -$21.7M | $367K | -$185.9M | |
Income Tax Expense | -$11.9M | $7.3M | $924K | $5.6M | -$6.7M | |
Net Income to Company | -$80.7M | -$25.5M | -$20.8M | $14.5M | -$150.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$80.7M | -$25.5M | -$20.8M | $14.5M | -$150.3M | |
Basic EPS (Cont. Ops) | -$0.89 | -$0.28 | -$0.22 | $0.17 | -$1.75 | |
Diluted EPS (Cont. Ops) | -$0.89 | -$0.28 | -$0.22 | $0.17 | -$1.75 | |
Weighted Average Basic Share | $90.2M | $91.5M | $92.7M | $86.4M | $85.8M | |
Weighted Average Diluted Share | $90.2M | $91.5M | $94M | $88.3M | $87.4M | |
EBITDA | -$36.3M | $32.8M | $43.9M | $55.2M | $59M | |
EBIT | -$81.6M | -$9.4M | $5.3M | $23.8M | $31.5M | |
Revenue (Reported) | $492.6M | $614.8M | $193M | $207.6M | $217.5M | |
Operating Income (Reported) | -$63.9M | -$8.8M | $14.4M | $22.9M | $32.4M | |
Operating Income (Adjusted) | -$81.6M | -$9.4M | $5.3M | $23.8M | $31.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $141.2M | $176.4M | $200M | $49M | $64.8M | |
Revenue Growth (YoY) | -14.21% | 24.98% | 13.37% | -75.52% | 32.29% | |
Cost of Revenues | $120M | $151M | $164.7M | $31.3M | $39.5M | |
Gross Profit | $21.2M | $25.5M | $35.3M | $17.6M | $25.3M | |
Gross Profit Margin | 15% | 14.42% | 17.64% | 36.03% | 38.98% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $20.9M | $24.4M | $25.4M | $11.6M | $11.7M | |
Other Inc / (Exp) | -$458K | -$64K | -$319K | -$245K | $314K | |
Operating Expenses | $20.6M | $24.5M | $25.1M | $10.7M | $11.7M | |
Operating Income | $544K | $967K | $10.1M | $7M | $13.5M | |
Net Interest Expenses | $2.4M | $1.2M | $2.1M | $760K | -- | |
EBT. Incl. Unusual Items | -$2.3M | -$303K | $7.7M | $6M | $13.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | $3.2M | -$372K | |
Income Tax Expense | $3M | -$2.8M | $2.1M | $1.9M | $3.5M | |
Net Income to Company | -$5.4M | $2.5M | $5.6M | $7.3M | $10M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$5.4M | $2.5M | $5.6M | $7.3M | $10M | |
Basic EPS (Cont. Ops) | -$0.06 | $0.03 | $0.06 | $0.09 | $0.12 | |
Diluted EPS (Cont. Ops) | -$0.06 | $0.03 | $0.06 | $0.08 | $0.11 | |
Weighted Average Basic Share | $90.7M | $92.1M | $88.6M | $85M | $86.1M | |
Weighted Average Diluted Share | $90.7M | $93.9M | $90.6M | $87M | $87M | |
EBITDA | $10.9M | $11.4M | $17.7M | $14.4M | $19.3M | |
EBIT | $86K | $903K | $9.8M | $7M | $13.5M | |
Revenue (Reported) | $141.2M | $176.4M | $200M | $49M | $64.8M | |
Operating Income (Reported) | $544K | $967K | $10.1M | $7M | $13.5M | |
Operating Income (Adjusted) | $86K | $903K | $9.8M | $7M | $13.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $469.2M | $650M | $216.6M | $335.9M | $345.5M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $447.2M | $560.5M | $146.8M | $249.7M | $246.7M | |
Gross Profit | $22.1M | $89.5M | $69.8M | $86.3M | $98.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $82.8M | $98M | $49.8M | $61.3M | $59.8M | |
Other Inc / (Exp) | -$15.2M | -$209K | -$9.4M | -$2.8M | $49K | |
Operating Expenses | $79.6M | $97.9M | $46.2M | $58.3M | $59.1M | |
Operating Income | -$57.5M | -$8.4M | $23.6M | $28M | $39.7M | |
Net Interest Expenses | $10.2M | $7.6M | $4.4M | $4.9M | $2.7M | |
EBT. Incl. Unusual Items | -$82.9M | -$16.2M | $9.8M | $20.4M | $37.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | $2.6M | -$188.9M | |
Income Tax Expense | -$9M | $1.4M | $5.9M | $6.8M | -$4.3M | |
Net Income to Company | -$73.9M | -$17.6M | -$17.7M | $16.2M | -$147.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$73.9M | -$17.6M | -$17.7M | $16.2M | -$147.6M | |
Basic EPS (Cont. Ops) | -$0.81 | -$0.19 | -$0.18 | $0.19 | -$1.71 | |
Diluted EPS (Cont. Ops) | -$0.81 | -$0.19 | -$0.18 | $0.18 | -$1.72 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$28M | $33.2M | $50.2M | $56.4M | $65.4M | |
EBIT | -$72.7M | -$8.6M | $14.2M | $25.5M | $39.4M | |
Revenue (Reported) | $469.2M | $650M | $216.6M | $335.9M | $345.5M | |
Operating Income (Reported) | -$57.5M | -$8.4M | $23.6M | $28M | $39.7M | |
Operating Income (Adjusted) | -$72.7M | -$8.6M | $14.2M | $25.5M | $39.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $141.2M | $176.4M | $200M | $49M | $64.8M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $120M | $151M | $164.7M | $31.3M | $39.5M | |
Gross Profit | $21.2M | $25.5M | $35.3M | $17.6M | $25.3M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $20.9M | $24.4M | $25.4M | $11.6M | $11.7M | |
Other Inc / (Exp) | -$458K | -$64K | -$319K | -$245K | $314K | |
Operating Expenses | $20.6M | $24.5M | $25.1M | $10.7M | $11.7M | |
Operating Income | $544K | $967K | $10.1M | $7M | $13.5M | |
Net Interest Expenses | $2.4M | $1.2M | $2.1M | $760K | -- | |
EBT. Incl. Unusual Items | -$2.3M | -$303K | $7.7M | $6M | $13.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | $3.2M | -$372K | |
Income Tax Expense | $3M | -$2.8M | $2.1M | $1.9M | $3.5M | |
Net Income to Company | -$5.4M | $2.5M | $5.6M | $7.3M | $10M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$5.4M | $2.5M | $5.6M | $7.3M | $10M | |
Basic EPS (Cont. Ops) | -$0.06 | $0.03 | $0.06 | $0.09 | $0.12 | |
Diluted EPS (Cont. Ops) | -$0.06 | $0.03 | $0.06 | $0.08 | $0.11 | |
Weighted Average Basic Share | $90.7M | $92.1M | $88.6M | $85M | $86.1M | |
Weighted Average Diluted Share | $90.7M | $93.9M | $90.6M | $87M | $87M | |
EBITDA | $10.9M | $11.4M | $17.7M | $14.4M | $19.3M | |
EBIT | $86K | $903K | $9.8M | $7M | $13.5M | |
Revenue (Reported) | $141.2M | $176.4M | $200M | $49M | $64.8M | |
Operating Income (Reported) | $544K | $967K | $10.1M | $7M | $13.5M | |
Operating Income (Adjusted) | $86K | $903K | $9.8M | $7M | $13.5M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $24.2M | $24.1M | $23.2M | $789K | $17.8M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $128.7M | $180.5M | $222.9M | $40.9M | $45.9M | |
Inventory | $147.9M | $155.3M | $149.6M | $18.6M | $14.7M | |
Prepaid Expenses | $15.1M | -- | -- | -- | -- | |
Other Current Assets | -- | $14.8M | $11M | $4.7M | $5.7M | |
Total Current Assets | $328.2M | $388.5M | $426M | $357.2M | $113M | |
Property Plant And Equipment | $308.7M | $287.8M | $216.9M | $176.7M | $199.3M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $42.4M | $47.3M | $47.1M | $47.3M | $47.2M | |
Other Intangibles | $25.4M | $25M | $20.2M | $12.5M | $10.3M | |
Other Long-Term Assets | $2.8M | $2M | $2.4M | $47.3M | $8.3M | |
Total Assets | $709.2M | $752.9M | $714.9M | $642.3M | $393.7M | |
Accounts Payable | $49.3M | $84.6M | $93.6M | $16.3M | $19.5M | |
Accrued Expenses | $36.9M | $46.6M | $46.9M | $21M | $22.3M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | $92.6M | -- | |
Total Current Liabilities | $153.7M | $150.4M | $162.9M | $136.3M | $44.7M | |
Long-Term Debt | $19.7M | $95.6M | $91.7M | $55.7M | $4.8M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $221.2M | $290.5M | $291.8M | $227M | $67.2M | |
Common Stock | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | |
Other Common Equity Adj | -$54.2M | -$61.5M | -$67.2M | -$62.8M | -$2.9M | |
Common Equity | $488M | $462.4M | $423M | $415.4M | $326.5M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $488M | $462.4M | $423M | $415.4M | $326.5M | |
Total Liabilities and Equity | $709.2M | $752.9M | $714.9M | $642.3M | $393.7M | |
Cash and Short Terms | $24.2M | $24.1M | $23.2M | $789K | $17.8M | |
Total Debt | $87.2M | $114.8M | $114.1M | $62M | $7.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $34.2M | $21.3M | $23.6M | $37.7M | $20.8M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $121.8M | $174.6M | $197.1M | $160.1M | $56.2M | |
Inventory | $139.9M | $170M | $150M | $131.6M | $9.6M | |
Prepaid Expenses | $13.3M | $14.3M | -- | -- | -- | |
Other Current Assets | -- | -- | $10M | $8.9M | $4.3M | |
Total Current Assets | $320.6M | $393.2M | $396.3M | $347.9M | $105.1M | |
Property Plant And Equipment | $305.3M | $284.3M | $217.2M | $224.1M | $205.6M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $42.5M | $47.4M | $47.2M | $47.3M | $47.3M | |
Other Intangibles | $24.5M | $23.4M | $19.5M | $16.3M | $9.8M | |
Other Long-Term Assets | $2.6M | $1.8M | $2.3M | $2M | $9.4M | |
Total Assets | $697.6M | $752.4M | $684.9M | $640.8M | $390M | |
Accounts Payable | $60.6M | $95.3M | $92.6M | $68.4M | $19.7M | |
Accrued Expenses | $35.2M | $37.3M | $37.8M | $39.8M | $17.6M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $151.1M | $153.4M | $153.5M | $124.6M | $40.4M | |
Long-Term Debt | $17M | $95.5M | $78M | $61M | $5M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $216.7M | $287.2M | $267.6M | $219.2M | $63.1M | |
Common Stock | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | |
Other Common Equity Adj | -$57.5M | -$62.7M | -$65.2M | -$65.4M | -$2.7M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $480.9M | $465.1M | $417.2M | $421.6M | $326.9M | |
Total Liabilities and Equity | $697.6M | $752.4M | $684.9M | $640.8M | $390M | |
Cash and Short Terms | $34.2M | $21.3M | $23.6M | $37.7M | $20.8M | |
Total Debt | $72.2M | $116.2M | $101.2M | $77.4M | $8.1M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$80.7M | -$25.5M | -$20.8M | $14.5M | -$150.3M | |
Depreciation & Amoritzation | $45.3M | $42.2M | $38.6M | $31.4M | $27.5M | |
Stock-Based Compensation | $6.6M | $7.9M | $6.9M | $6.6M | $5.2M | |
Change in Accounts Receivable | $71M | -$61.3M | -$42.5M | $64.8M | -$28M | |
Change in Inventories | $39.9M | -$10.3M | -$46.9M | $2.3M | $9.7M | |
Cash From Operations | $55.8M | -$3M | -$25M | $100M | $38.2M | |
Capital Expenditures | $15.8M | $21.8M | $28.3M | $29.2M | $43.5M | |
Cash Acquisitions | -- | -$13.4M | $71.3M | $19.8M | $48.5M | |
Cash From Investing | -$3.4M | -$17.5M | $46.2M | -$5.7M | $8.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $173.8M | $302.4M | $291M | $241.9M | $177.5M | |
Long-Term Debt Repaid | -$250.9M | -$275.3M | -$290.9M | -$277.6M | -$224.3M | |
Repurchase of Common Stock | -$333K | -$1.4M | -$20.2M | -$34.3M | -$4.5M | |
Other Financing Activities | -$497K | -$4.3M | -$4.8M | -$11.7M | -$15.8M | |
Cash From Financing | -$77.9M | $21.4M | -$24.9M | -$81M | -$66.9M | |
Beginning Cash (CF) | $56.9M | $30.3M | $29.5M | $25.1M | $38.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$25.5M | $920K | -$3.7M | $13.3M | -$20.5M | |
Ending Cash (CF) | $30.3M | $29.5M | $25.1M | $38.9M | $18.2M | |
Levered Free Cash Flow | $40M | -$24.8M | -$53.3M | $70.8M | -$5.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$5.4M | $2.5M | $5.6M | $7.3M | $10M | |
Depreciation & Amoritzation | $10.8M | $10.5M | $7.9M | $7.4M | $5.8M | |
Stock-Based Compensation | $1.3M | $1.5M | $1.7M | $1.5M | $1.2M | |
Change in Accounts Receivable | $2.4M | $5.8M | $27.3M | -$3.1M | -$10M | |
Change in Inventories | $6.7M | -$14.8M | -$3.9M | $8.3M | $5.1M | |
Cash From Operations | $27.8M | $2.8M | $29.4M | $12M | $8.8M | |
Capital Expenditures | $8.6M | $7.6M | $7M | $13.9M | $10M | |
Cash Acquisitions | -- | -- | $7.2M | -- | $10.7M | |
Cash From Investing | -$622K | -$7M | $921K | -$12.7M | $5.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $60.2M | $69.2M | $76.4M | $52.6M | -- | |
Long-Term Debt Repaid | -$75M | -$65.2M | -$90.2M | -$48.6M | -- | |
Repurchase of Common Stock | -$6K | -$4K | -$15M | -- | -$10.8M | |
Other Financing Activities | -$1.8M | -$2.7M | -$1.5M | -$3.4M | -$865K | |
Cash From Financing | -$16.6M | $1.3M | -$30.3M | $589K | -$11.7M | |
Beginning Cash (CF) | $30.3M | $29.5M | $25.1M | $38.9M | $18.2M | |
Foreign Exchange Rate Adjustment | -$882K | -$376K | $375K | -$761K | $26K | |
Additions / Reductions | $10.5M | -$3M | $95K | -$200K | $2.6M | |
Ending Cash (CF) | $40M | $26.1M | $25.5M | $37.9M | $20.8M | |
Levered Free Cash Flow | $19.1M | -$4.8M | $22.5M | -$1.9M | -$1.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$73.9M | -$17.6M | -$17.7M | $16.2M | -$147.6M | |
Depreciation & Amoritzation | $44.7M | $41.8M | $36.1M | $30.9M | $25.9M | |
Stock-Based Compensation | $6.3M | $8.1M | $7.1M | $6.4M | $4.9M | |
Change in Accounts Receivable | $62.8M | -$57.9M | -$21M | $34.4M | -$34.9M | |
Change in Inventories | $41.1M | -$31.8M | -$36M | $14.4M | $6.6M | |
Cash From Operations | $79.2M | -$28M | $1.6M | $82.5M | $35M | |
Capital Expenditures | $17.8M | $20.8M | $27.6M | $36.1M | $39.7M | |
Cash Acquisitions | -- | -- | $78.4M | $12.7M | $59.2M | |
Cash From Investing | -$1M | -$23.9M | $54.2M | -$19.4M | $26.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $159.1M | $311.4M | $298.3M | $218M | $125M | |
Long-Term Debt Repaid | -$253.2M | -$265.5M | -$315.9M | -$236M | -$175.7M | |
Repurchase of Common Stock | -$307K | -$1.4M | -$35.3M | -$19.3M | -$15.3M | |
Other Financing Activities | -$1M | -$5.2M | -$3.6M | -$13.5M | -$13.3M | |
Cash From Financing | -$95.5M | $39.3M | -$56.5M | -$50.2M | -$79.1M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$17.4M | -$12.6M | -$641K | $13M | -$17.7M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $61.4M | -$48.8M | -$26M | $46.4M | -$4.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$5.4M | $2.5M | $5.6M | $7.3M | $10M | |
Depreciation & Amoritzation | $10.8M | $10.5M | $7.9M | $7.4M | $5.8M | |
Stock-Based Compensation | $1.3M | $1.5M | $1.7M | $1.5M | $1.2M | |
Change in Accounts Receivable | $2.4M | $5.8M | $27.3M | -$3.1M | -$10M | |
Change in Inventories | $6.7M | -$14.8M | -$3.9M | $8.3M | $5.1M | |
Cash From Operations | $27.8M | $2.8M | $29.4M | $12M | $8.8M | |
Capital Expenditures | $8.6M | $7.6M | $7M | $13.9M | $10M | |
Cash Acquisitions | -- | -- | $7.2M | -- | $10.7M | |
Cash From Investing | -$622K | -$7M | $921K | -$12.7M | $5.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $60.2M | $69.2M | $76.4M | $52.6M | -- | |
Long-Term Debt Repaid | -$75M | -$65.2M | -$90.2M | -$48.6M | -- | |
Repurchase of Common Stock | -$6K | -$4K | -$15M | -- | -$10.8M | |
Other Financing Activities | -$1.8M | -$2.7M | -$1.5M | -$3.4M | -$865K | |
Cash From Financing | -$16.6M | $1.3M | -$30.3M | $589K | -$11.7M | |
Beginning Cash (CF) | $30.3M | $29.5M | $25.1M | $38.9M | $18.2M | |
Foreign Exchange Rate Adjustment | -$882K | -$376K | $375K | -$761K | $26K | |
Additions / Reductions | $10.5M | -$3M | $95K | -$200K | $2.6M | |
Ending Cash (CF) | $40M | $26.1M | $25.5M | $37.9M | $20.8M | |
Levered Free Cash Flow | $19.1M | -$4.8M | $22.5M | -$1.9M | -$1.2M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.